NCT Number: NCT01966081
AGARIC Case Control Study
The aim of the study is to establish the existence of a relationship between the dietary intake of polyunsaturated fatty acids (PUFA) and the risk of colorectal cancer in humans, using 2 reliable and complementary biomarkers: the fatty acid-composition of lipids of the abdominal subcutaneous adipose tissue and the fatty acid composition of erythrocyte phospholipids.
Looking for future studies?
Notify MeKey information
Conditions
Age range
45 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
CHU Jean Minjoz, Besançon, France
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
CASES
- Patients aged ≥ 45 years
- with a first recently-diagnosed colorectal cancer
- due to undergo elective surgical resection with curative intent (in practice, stage I, II, III or IV if there was only one hepatic nodule that was resected with curative intent) in one of the 5 following digestive surgery units: CHU de Dijon, CHU de Nancy, CHU de Strasbourg, CHU de Reims et CHU and Besançon.
- who have given their informed consent
CONTROLS
- Patients aged ≥ 45 years
- due to undergo surgery for a benign abdominal disease (sigmoid diverticulitis, appendectomy, hiatal hernia …)
- matched for abdominal site with cases for age (± 3 years), sex and hospital
- Who have given their informed consent
Exclusion criteria
CASES
- pre-operative anticancer treatment (chemo or radiotherapy)
- existence of visceral metastases except a single hepatic nodule resected with curative intent
- familial adenomatous polyposis and HNPCC syndrome (when suspected: inclusion after complementary tumor phenotype study: screening for microsatellite instability and/or immunohistochemistry study of the expression of DNA mismatch repair proteins.
- known inflammatory disease of the intestine (ulcerative colitis, Crohn's disease)
- personal history (recent or not) of colorectal cancer
- emergency treatment for the presenting complication (perforation, occlusion…)
- significant modification in dietary habits during the previous three months
- other evolving neoplastic disease
- psychic state incompatible with understanding the modalities and the aims of the study (notably patients under guardianship)
- pregnant or breast-feeding women
CONTROLS
- personal history of cancer or adenomatous colorectal polyps,
- emergency intervention
- known inflammatory disease of the intestine (ulcerative colitis, Crohn's disease)
- personal history (recent or not) of colorectal cancer
- emergency treatment for the presenting complication (perforation, occlusion…)
- significant modification in dietary habits during the previous three months
- evolving neoplastic disease
- psychic state incompatible with understanding the modalities and the aims of the study (notably patients under guardianship)
- pregnant or breast-feeding women
Treatment and study plan
tissue samples from abdominal subcutaneous adipose
OtherPrimary outcomes
-
Measure of polyunsaturated fatty acids in adipose tissue lipids.
Time frame: baselines
Sponsors and collaborators
Lead sponsor
Centre Hospitalier Universitaire Dijon
Other
Registry information
Official study title
Consumption of Fatty Acids, Metabolism of Adipose Tissue and Risk of Colorectal Cancer: AGARIC Case Control Study
Acronym: AGARIC
Important dates
- Study start
- 2008
- Primary completion
- 2011
- Study completion
- 2011
- First posted
- Oct 21, 2013
- Registry last updated
- Feb 9, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.